Clinical trial
Novel Medical Adjunctive Therapy to Catheter Ablation For Atrial Fibrillation (AF)
NCT03856632 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Medical Adjunctive Therapy to Catheter Ablation For Atrial Fibrillation (AF)
- Lead sponsor
- University of Miami
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- March 18, 2019
- Completion date
- December 31, 2026
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.